SEMNUR PHARMACEUTICALS
Semnur Pharmaceuticals, Inc. is an emerging specialty pharmaceutical company focused on the clinical and commercial development of innovative products that meet the needs of pain management practitioners and their patients.
SEMNUR PHARMACEUTICALS
Industry:
Biotechnology Life Science Pharmaceutical
Founded:
2013-01-01
Address:
Los Altos, California, United States
Country:
United States
Website Url:
http://www.semnurpharma.com
Total Employee:
1+
Status:
Active
Contact:
888-315-8706
Email Addresses:
[email protected]
Total Funding:
6 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt WordPress Google Universal Analytics Apache
Similar Organizations
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Current Advisors List
Current Employees Featured
Investors List
Vivo Capital
Vivo Capital investment in Venture Round - Semnur Pharmaceuticals
Canaan Partners
Canaan Partners investment in Venture Round - Semnur Pharmaceuticals
Frazier Healthcare Partners
Frazier Healthcare Partners investment in Venture Round - Semnur Pharmaceuticals
Official Site Inspections
http://www.semnurpharma.com
- Host name: 74-208-236-40.elastic-ssl.ui-r.com
- IP address: 74.208.236.40
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Semnur Pharmaceuticals"
Semnurpharma – Getting back to normal
Back pain affects most adults, causes disability for some, and is a common reason for seeking healthcare. In the United States, opioid prescription for low back pain has increased, and opioids are now the most commonly prescribed …See details»
Overview – Semnurpharma
Novel Non-opioid Pain Management Medications Under Development. Semnur Pharmaceuticals, Inc. is a biopharmaceutical company focused on the clinical and commercial development of …See details»
Semnur Pharmaceuticals, Inc. | LinkedIn
Semnur Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the clinical and commercial development of innovative products and therapeutics that meet the needs of pain …See details»
Our Team – Semnurpharma
Semnurpharma - Getting back to normal Getting back to normal. About. Overview; Leadership Team; Board of Directors; Our Culture; Partners; Chronic Back Pain. Chronic Back Pain; SP …See details»
Semnur Pharmaceuticals - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number 888-315-8706 Semnur Pharmaceuticals, Inc. is an emerging specialty pharmaceutical company focused on the …See details»
Semnur Pharmaceuticals Company Profile | Management and
Www.semnurpharma.com Semnur Pharmaceuticals Profile and History Semnur Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the clinical and commercial …See details»
Semnur Pharmaceuticals - PitchBook
Semnur Pharmaceuticals General Information Description. Developer of non-opioid drugs designed for the treatment of lumbar radicular pain. The company's drugs focus on the clinical …See details»
Semnur Pharmaceuticals - VentureRadar
Semnur develops innovative products for pain management practitioners and their patients. ... Find out more about Semnur Pharmaceuticals, Healthcare, Life Sciences and Specialty …See details»
Partners – Semnurpharma
Semnurpharma - Getting back to normal Getting back to normal. About. Overview; Leadership Team; Board of Directors; Our Culture; Partners; Chronic Back Pain. Chronic Back Pain; SP …See details»
Semnur Pharmaceuticals - Craft
See insights on Semnur Pharmaceuticals including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
Semnur Pharmaceuticals, Inc. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Semnur Pharmaceuticals, Inc. of Palo Alto, CA. Get the latest business insights from Dun & Bradstreet.See details»
Overview, News & Similar companies - ZoomInfo.com
Jan 7, 2018 Who is Semnur Pharmaceuticals. Semnur Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the clinical and commercial development of innovative …See details»
Semnur Pharmaceuticals, Inc., a Wholly Owned Subsidiary of Scilex ...
Nov 6, 2024 As previously announced, Semnur Pharmaceuticals, Inc. (“Semnur”), a wholly owned subsidiary of Scilex Holding Company, and Denali Capital Acquisition Corp. (Nasdaq: …See details»
Investor Overview – Semnurpharma
Semnur Pharmaceuticals, Inc., a Wholly Owned Subsidiary of Scilex Holding Company, Announces on November 6th, 2024 the Filing of a Registration Statement on Form S-4 by …See details»
Semnur Pharmaceuticals to go public in SPAC deal of up to $2 …
Jul 2, 2024 Drug developer Semnur Pharmaceuticals said on Tuesday it has signed a letter of intent to go public through a merger with special purpose acquisition company Denali Capital …See details»
Leadership Team – Semnurpharma
Henry Ji brings 25+ years of experience in the biotechnology and life sciences industry. Dr. Ji has been Chairman of Scilex from March 2019 to present and served as the CEO of Scilex …See details»
Semnur Pharmaceuticals, Inc., a Wholly Owned Subsidiary of Scilex ...
Sep 3, 2024 Semnur Pharmaceuticals, Inc. (“Semnur”), a wholly owned subsidiary of Scilex Holding Company (Nasdaq: SCLX, “Scilex”), and Denali Capital Acquisition Corp. (Nasdaq: …See details»
Semnur Pharmaceuticals Begins Pivotal Phase 3 Trial For SP-102 In ...
Jan 7, 2018 For more information, visit www.semnurpharma.com or www.clearbackpainstudy.com. Follow us on LinkedIn , Facebook , Twitter , and Clear Back …See details»
Our Culture – Semnurpharma
Our Culture. At Semnur Pharmaceuticals, we are not just your average pharmaceutical company. We are a passionate team of talented individuals united by a shared mission to make a …See details»
NEWS – Semnurpharma
Semnur Pharmaceuticals, Inc., a Wholly Owned Subsidiary of Scilex Holding Company, Announces on November 6th, 2024 the Filing of a Registration Statement on Form S-4 by …See details»